SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout AfricaBOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™. Syndicate Bio is the first lab in Africa to adopt the MSK-ACCESS® assay via the SOPHiA DDM™ Platform, and the ...